Report cover image

Global Medication for Dental Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 200 Pages
SKU # APRC20360126

Description

Summary

According to APO Research, the global Medication for Dental market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Medication for Dental market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Medication for Dental is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Medication for Dental market include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Medication for Dental, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Medication for Dental, also provides the value of main regions and countries. Of the upcoming market potential for Medication for Dental, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medication for Dental revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Medication for Dental market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Medication for Dental company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Medication for Dental Segment by Company

Teva
Sun Pharmaceutical
Johnson & Johnson
Qilu Pharmaceutical
Novartis
Mylan
GSK
Bayer
Lupin
Lingrui
Galderma
Dr. Reddy's
CR SANJIU
Cipla
Bausch Health
Aurobindo
Almirall
Medication for Dental Segment by Type

NSAID
OTC Analgesic Medications
Opioid
Medication for Dental Segment by Application

Drug Store
Hospital
Other
Medication for Dental Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Medication for Dental status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medication for Dental key companies, revenue, market share, and recent developments.
3. To split the Medication for Dental breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medication for Dental market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medication for Dental significant trends, drivers, influence factors in global and regions.
6. To analyze Medication for Dental competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medication for Dental market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medication for Dental and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medication for Dental.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medication for Dental industry.
Chapter 3: Detailed analysis of Medication for Dental company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medication for Dental in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medication for Dental in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

200 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Medication for Dental Market Size, 2020 VS 2024 VS 2031
1.3 Global Medication for Dental Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Medication for Dental Market Dynamics
2.1 Medication for Dental Industry Trends
2.2 Medication for Dental Industry Drivers
2.3 Medication for Dental Industry Opportunities and Challenges
2.4 Medication for Dental Industry Restraints
3 Medication for Dental Market by Company
3.1 Global Medication for Dental Company Revenue Ranking in 2024
3.2 Global Medication for Dental Revenue by Company (2020-2025)
3.3 Global Medication for Dental Company Ranking (2023-2025)
3.4 Global Medication for Dental Company Manufacturing Base and Headquarters
3.5 Global Medication for Dental Company Product Type and Application
3.6 Global Medication for Dental Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Medication for Dental Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Medication for Dental Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Medication for Dental Market by Type
4.1 Medication for Dental Type Introduction
4.1.1 NSAID
4.1.2 OTC Analgesic Medications
4.1.3 Opioid
4.2 Global Medication for Dental Sales Value by Type
4.2.1 Global Medication for Dental Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Medication for Dental Sales Value by Type (2020-2031)
4.2.3 Global Medication for Dental Sales Value Share by Type (2020-2031)
5 Medication for Dental Market by Application
5.1 Medication for Dental Application Introduction
5.1.1 Drug Store
5.1.2 Hospital
5.1.3 Other
5.2 Global Medication for Dental Sales Value by Application
5.2.1 Global Medication for Dental Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Medication for Dental Sales Value by Application (2020-2031)
5.2.3 Global Medication for Dental Sales Value Share by Application (2020-2031)
6 Medication for Dental Regional Value Analysis
6.1 Global Medication for Dental Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Medication for Dental Sales Value by Region (2020-2031)
6.2.1 Global Medication for Dental Sales Value by Region: 2020-2025
6.2.2 Global Medication for Dental Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Medication for Dental Sales Value (2020-2031)
6.3.2 North America Medication for Dental Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Medication for Dental Sales Value (2020-2031)
6.4.2 Europe Medication for Dental Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Medication for Dental Sales Value (2020-2031)
6.5.2 Asia-Pacific Medication for Dental Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Medication for Dental Sales Value (2020-2031)
6.6.2 South America Medication for Dental Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Medication for Dental Sales Value (2020-2031)
6.7.2 Middle East & Africa Medication for Dental Sales Value Share by Country, 2024 VS 2031
7 Medication for Dental Country-level Value Analysis
7.1 Global Medication for Dental Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Medication for Dental Sales Value by Country (2020-2031)
7.2.1 Global Medication for Dental Sales Value by Country (2020-2025)
7.2.2 Global Medication for Dental Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Medication for Dental Sales Value Growth Rate (2020-2031)
7.3.2 USA Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Medication for Dental Sales Value Growth Rate (2020-2031)
7.4.2 Canada Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Medication for Dental Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Medication for Dental Sales Value Growth Rate (2020-2031)
7.6.2 Germany Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Medication for Dental Sales Value Growth Rate (2020-2031)
7.7.2 France Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.7.3 France Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Medication for Dental Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Medication for Dental Sales Value Growth Rate (2020-2031)
7.9.2 Italy Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Medication for Dental Sales Value Growth Rate (2020-2031)
7.10.2 Spain Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Medication for Dental Sales Value Growth Rate (2020-2031)
7.11.2 Russia Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Medication for Dental Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Medication for Dental Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Medication for Dental Sales Value Growth Rate (2020-2031)
7.14.2 China Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.14.3 China Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Medication for Dental Sales Value Growth Rate (2020-2031)
7.15.2 Japan Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Medication for Dental Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Medication for Dental Sales Value Growth Rate (2020-2031)
7.17.2 India Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.17.3 India Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Medication for Dental Sales Value Growth Rate (2020-2031)
7.18.2 Australia Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Medication for Dental Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Medication for Dental Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Medication for Dental Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Medication for Dental Sales Value Growth Rate (2020-2031)
7.22.2 Chile Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Medication for Dental Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Medication for Dental Sales Value Growth Rate (2020-2031)
7.24.2 Peru Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Medication for Dental Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Medication for Dental Sales Value Growth Rate (2020-2031)
7.26.2 Israel Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Medication for Dental Sales Value Growth Rate (2020-2031)
7.27.2 UAE Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Medication for Dental Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Medication for Dental Sales Value Growth Rate (2020-2031)
7.29.2 Iran Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Medication for Dental Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Medication for Dental Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Medication for Dental Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Medication for Dental Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Medication for Dental Revenue and Gross Margin (2020-2025)
8.1.4 Teva Medication for Dental Product Portfolio
8.1.5 Teva Recent Developments
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Comapny Information
8.2.2 Sun Pharmaceutical Business Overview
8.2.3 Sun Pharmaceutical Medication for Dental Revenue and Gross Margin (2020-2025)
8.2.4 Sun Pharmaceutical Medication for Dental Product Portfolio
8.2.5 Sun Pharmaceutical Recent Developments
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Comapny Information
8.3.2 Johnson & Johnson Business Overview
8.3.3 Johnson & Johnson Medication for Dental Revenue and Gross Margin (2020-2025)
8.3.4 Johnson & Johnson Medication for Dental Product Portfolio
8.3.5 Johnson & Johnson Recent Developments
8.4 Qilu Pharmaceutical
8.4.1 Qilu Pharmaceutical Comapny Information
8.4.2 Qilu Pharmaceutical Business Overview
8.4.3 Qilu Pharmaceutical Medication for Dental Revenue and Gross Margin (2020-2025)
8.4.4 Qilu Pharmaceutical Medication for Dental Product Portfolio
8.4.5 Qilu Pharmaceutical Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Medication for Dental Revenue and Gross Margin (2020-2025)
8.5.4 Novartis Medication for Dental Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Mylan
8.6.1 Mylan Comapny Information
8.6.2 Mylan Business Overview
8.6.3 Mylan Medication for Dental Revenue and Gross Margin (2020-2025)
8.6.4 Mylan Medication for Dental Product Portfolio
8.6.5 Mylan Recent Developments
8.7 GSK
8.7.1 GSK Comapny Information
8.7.2 GSK Business Overview
8.7.3 GSK Medication for Dental Revenue and Gross Margin (2020-2025)
8.7.4 GSK Medication for Dental Product Portfolio
8.7.5 GSK Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Medication for Dental Revenue and Gross Margin (2020-2025)
8.8.4 Bayer Medication for Dental Product Portfolio
8.8.5 Bayer Recent Developments
8.9 Lupin
8.9.1 Lupin Comapny Information
8.9.2 Lupin Business Overview
8.9.3 Lupin Medication for Dental Revenue and Gross Margin (2020-2025)
8.9.4 Lupin Medication for Dental Product Portfolio
8.9.5 Lupin Recent Developments
8.10 Lingrui
8.10.1 Lingrui Comapny Information
8.10.2 Lingrui Business Overview
8.10.3 Lingrui Medication for Dental Revenue and Gross Margin (2020-2025)
8.10.4 Lingrui Medication for Dental Product Portfolio
8.10.5 Lingrui Recent Developments
8.11 Galderma
8.11.1 Galderma Comapny Information
8.11.2 Galderma Business Overview
8.11.3 Galderma Medication for Dental Revenue and Gross Margin (2020-2025)
8.11.4 Galderma Medication for Dental Product Portfolio
8.11.5 Galderma Recent Developments
8.12 Dr. Reddy's
8.12.1 Dr. Reddy's Comapny Information
8.12.2 Dr. Reddy's Business Overview
8.12.3 Dr. Reddy's Medication for Dental Revenue and Gross Margin (2020-2025)
8.12.4 Dr. Reddy's Medication for Dental Product Portfolio
8.12.5 Dr. Reddy's Recent Developments
8.13 CR SANJIU
8.13.1 CR SANJIU Comapny Information
8.13.2 CR SANJIU Business Overview
8.13.3 CR SANJIU Medication for Dental Revenue and Gross Margin (2020-2025)
8.13.4 CR SANJIU Medication for Dental Product Portfolio
8.13.5 CR SANJIU Recent Developments
8.14 Cipla
8.14.1 Cipla Comapny Information
8.14.2 Cipla Business Overview
8.14.3 Cipla Medication for Dental Revenue and Gross Margin (2020-2025)
8.14.4 Cipla Medication for Dental Product Portfolio
8.14.5 Cipla Recent Developments
8.15 Bausch Health
8.15.1 Bausch Health Comapny Information
8.15.2 Bausch Health Business Overview
8.15.3 Bausch Health Medication for Dental Revenue and Gross Margin (2020-2025)
8.15.4 Bausch Health Medication for Dental Product Portfolio
8.15.5 Bausch Health Recent Developments
8.16 Aurobindo
8.16.1 Aurobindo Comapny Information
8.16.2 Aurobindo Business Overview
8.16.3 Aurobindo Medication for Dental Revenue and Gross Margin (2020-2025)
8.16.4 Aurobindo Medication for Dental Product Portfolio
8.16.5 Aurobindo Recent Developments
8.17 Almirall
8.17.1 Almirall Comapny Information
8.17.2 Almirall Business Overview
8.17.3 Almirall Medication for Dental Revenue and Gross Margin (2020-2025)
8.17.4 Almirall Medication for Dental Product Portfolio
8.17.5 Almirall Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.